FindTrial
Sign In

Different dyskinesias in Parkinson's disease and their relation to levodopa pharmacokinetics - The dyskinesia study

Different dyskinesias in Parkinson's disease and their relation to levodopa pharmacokinetics - The dyskinesia study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-004985-41-SE
Enrollment
Unknown
Registered
2007-10-10
Start date
2007-11-29
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease, G20.9. Different dyskinesias related to advanced Parkinson's disease will be investigated.

Interventions

Trade Name: Duodopa Pharmaceutical Form: Gel INN or Proposed INN: levodopa CAS Number: 59-92-7 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 20- INN

Sponsors

Department of Neuroscience, neurology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Clinically diagnosed idiopathic Parkinson's disease with dyskinesias in spite of ongoing treatment with Duodopa. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Dementia.

Design outcomes

Primary

MeasureTime frame
Main Objective: To study the relationship between different kinds of dyskinesias and plasma levodopa levels.;Secondary Objective: To study if bradykinesia and dyskinesia can occur simultaneously.;Primary end point(s): Correlation of defined motor states (bradykinesia, dystonia, chorea) to plasma concentration levels of levodopa.—

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026